Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib

Overview of attention for article published in British Journal of Urology, April 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

blogs: 1 blog

twitter: 7 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 27,589 followers.

Outcomes of systemic targeted therapy in recurrent RCC Renal Cell Carcinoma treated with adjuvant sunitinib https://t.co/Oa4vaslfgO #Urology

Outcomes of systemic targeted therapy in recurrent RCC Renal Cell Carcinoma treated with adjuvant sunitinib 🔗 https://t.co/Oa4vasCQ8m #Urology https://t.co/Z5H9qUMoeT

RT @BJUIjournal: Online now: Outcomes of systemic targeted therapy in recurrent #RenalCellCarcinoma treated with adjuvant sunitinib https:…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.